Proton motive force mediates a reorientation of the cytosolic domains of the multidrug transporter LmrP by Gbaguidi, B. et al.
  
 University of Groningen
Proton motive force mediates a reorientation of the cytosolic domains of the multidrug
transporter LmrP
Gbaguidi, B.; Mazurkiewicz, P.; Konings, W.N; Driessen, A.J.M.; Ruysschaert, J.M.; Vigano,
C.
Published in:
Cellular and molecular life sciences
DOI:
10.1007/s00018-004-4298-2
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2004
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Gbaguidi, B., Mazurkiewicz, P., Konings, W. N., Driessen, A. J. M., Ruysschaert, J. M., & Vigano, C.
(2004). Proton motive force mediates a reorientation of the cytosolic domains of the multidrug transporter
LmrP. Cellular and molecular life sciences, 61(19-20), 2646 - 2657. https://doi.org/10.1007/s00018-004-
4298-2
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Research Article
Proton motive force mediates a reorientation of the cytosolic
domains of the multidrug transporter LmrP
B. Gbaguidi a, P. Mazurkiewiczb, W. N. Konings b, A. J. M. Driessenb, J. M. Ruysschaerta, * and C. Viganoa
a Laboratory for the Structure and Function of Biological Membranes, Structural Biology and Bioinformatics Center,
Free University of Brussels, CP206/2, Bd du Triomphe, 1050 Brussels (Belgium), Fax +32 2 6505382, 
e-mail: jmruyss@ulb.ac.be
b Department of Microbiology, Groningen Biomolecular Sciences and Biotechnology Institute, University of Gronin-
gen, 9751 NN Haren (The Netherlands)
Received 3 August 2004; accepted 24 August 2004 
Abstract. LmrP from Lactococcus lactis is a 45-kDa
membrane protein that confers resistance to a wide vari-
ety of lipophilic compounds by acting as a proton motive
force-driven efflux pump. This study shows that both the
proton motive force and ligand interaction alter the ac-
cessibility of cytosolic tryptophan residues to a hydro-
philic quencher. The proton motive force mediates an in-
crease of LmrP accessibility toward the external medium
and results in higher drug binding. Residues Asp128 and
Asp68, from cytosolic loops, are involved in the proton
motive force-mediated accessibility change. Ligand
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binding does not modify the protein accessibility, but the
proton motive force-mediated restructuring is prerequi-
site for a subsequent accessibility change mediated by
ligand binding. Asp142 cooperates with other membrane-
embedded carboxylic residues to promote a conforma-
tional change that increases LmrP accessibility toward:
the hydrophilic quencher. This drug binding-mediated re-
organization may be related to the transition between the
high- and low-affinity drug-binding sites and is crucial
for drug release in the extracellular medium. 
Key words. Accessibility change; LmrP; multidrug resistance; proton motive force.
Resistance to a wide range of cytotoxic compounds is a
common phenomenon observed in many organisms rang-
ing from bacteria to humans [1, 2]. One important mech-
anism that organisms use to evade the lethal effect of cy-
totoxic drugs is the active efflux of the toxic compounds
out of the cell through the action of transporters. In con-
trast to specific drug efflux systems, multidrug resistance
(MDR) transporters can extrude a wide variety of struc-
turally unrelated compounds. The structural basis of their
broad chemical specificity is fairly well understood
[3–5] but the mechanism of the energy coupling to the
drug transport still awaits elucidation.
* Corresponding author.
Most known bacterial MDR transporters are secondary
transporters that use the proton motive force (pmf) to drive
the excretion of drugs. Secondary MDR transporters be-
long to one of three distinct families of transport proteins
which are distinguished on the basis of their structure: the
major facilitator superfamily (MFS) [6], the resistance-
nodulation-division family (RND) [7], and the small mul-
tidrug resistance family (SMR) [8]. In Gram-positive Lac-
tococcus lactis, several drug extrusion activities have been
detected, among which is the pmf-driven extrusion of
cationic drugs mediated by the MDR transporter LmrP
[9–11]. LmrP is a 408-amino-acid integral membrane pro-
tein that belongs to the MFS. Extrusion of drugs by LmrP
is driven by both the membrane potential and the trans-
membrane proton gradient (DpH), indicating that LmrP
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mediates an electrogenic proton/drug antiport reaction.
The number of compounds recognized and transported by
LmrP is remarkably broad and includes many structurally
diverse cytotoxic drugs such as lincosamides, macrolides,
streptogramins, and tetracyclines [12]. A common prop-
erty of most known substrates of LmrP is their ability to in-
tercalate into the lipid bilayer because of their lipophilicity.
This led to the hypothesis that LmrP recognizes its sub-
strates within the membrane and not from the cytoplasm.
Such a mechanism has been confirmed by transport ex-
periments with the fluorescent membrane probe 1-[4-
(trimethylamino)phenyl]-6-phenylhexa-1,3,5-triene [13].
The presence of multiple drug-binding sites in LmrP has
been reported [14] and can explain the large range of po-
tential drug-protein interactions. 
To mediate drug binding in the membrane and subse-
quent release in the external medium, LmrP must pass
through at least two configurations: a high-affinity mem-
brane-facing drug-binding site and a low-affinity, out-
side-facing site for drug release. High-resolution struc-
tures of the Escherichia coli MDR transporter AcrB in its
ligand-free and ligand-bound states [5, 15] revealed that
substrate binding only mediates small conformational
changes. This suggests that the proton flux is needed to
mediate the large conformational changes required for
drug extrusion by ion-coupled transporters [5]. Such an
influence of the pmf on transporter structures can not be
detected in crystal structures. Our study brings the first
experimental evidence that a DpH imposed across the li-
pidic bilayer indeed modifies the accessibility of a MDR
transporter to a hydrophilic quencher. This restructuring
results in an increase in the drug affinity of LmrP and is
necessary for subsequent reorientation mediated by drug
binding. This drug binding-mediated reorganization may
be related to the transition between the high- and low-
affinity drug-binding sites described above and hence be
crucial for drug release in the extracellular medium. 
Comprehension of the LmrP transport requires a better
knowledge of the coupling of H+ to substrate transloca-
tion. The importance of charged residues in transmem-
brane domains in such transport activity has been de-
scribed in several MDR ion-coupled transporters [4, 16,
17]. In EmrE from E. coli, a single membrane-embedded
charged carboxyl residue is part of a common binding site
for substrates and protons [18]. Therefore, EmrE shows a
simple mode of coupling and has been proposed as a
model system. However, other MDR ion-coupled sys-
tems may require a more complex mode of coupling pro-
ton to substrate translocation. LmrP mutagenesis experi-
ments have shown that several carboxylic residues lo-
cated in membrane helices and also extramembrane loops
are crucial to preserve LmrP transport activity [19].
Whether these residues are essential to preserve LmrP
structure, to modulate its substrate affinity, or to induce
conformational changes involved in the proton-coupled
drug transport is unknown. In this study, we demonstrate
that extramembrane carboxylic residues Asp68 and Asp128
are essential to preserve the drastic and essential pmf-me-
diated reorganization, and that the extramembrane Asp68
modulates ligand binding, in addition to transmembrane
residues such as Asp142. After ligand binding, Asp142 co-
operates with other membrane-embedded residues to pro-
mote the accessibility towards the hydrophilic quencher. 
Materials and methods
Materials
Ni2+-nitrilotriacetic acid (Ni-NTA)-agarose was from Qi-
agen; E. coli lipids and egg yolk phosphatidylcholine
were from Avanti Polar Lipids; dodecyl-b-D-maltoside
(DDM) was from Anatrace; pyranine, dicyclohexylcar-
bodiimide (DCCD), 1-ethyl-3(3-dimethylaminopropyl)
carbodiimide (EDAC), Triton X-100, verapamil, tetracy-
cline, valinomycin, and ethidium bromide were from
Sigma-Aldrich; acrylamide was from Merck; vinblastine
was from Fluka; [3H]tetracycline was from Perkin-Elmer
Life Sciences, and Hoechst 33342 was from Molecular
Probes.
Bacterial strains and growth conditions
L. lactis NZ9000 (DlmrA) [20] which lacks the gene en-
coding ATP-binding cassette-type MDR transporter
LmrA (a kind gift from O. Gajic and J. Kok, Department
of Genetics, University of Groningen) was used in com-
bination with the NICE system [21, 22] for overexpres-
sion of wild type (WT) and D68C, D128C and D142A
mutants of LmrP [19, 23, 24]. L. lactis cells were grown
at 30°C in M17 medium (Difco) supplemented with
0.5 % (w/v) glucose and 5 µg/ml chloramphenicol. Ex-
pression of LmrP variants was induced by adding ap-
proximately 10 ng nisin A per milliliter at an A660 of about
0.6, and cells were harvested 60 min after induction.
Purification and reconstitution of LmrP
His-tagged WT or mutated LmrP were purified by affin-
ity chromatography using Ni-NTA-agarose as described
elsewhere [19]. Briefly, solubilized membrane proteins
were mixed with Ni-NTA resin (~25 µl resin/mg of pro-
tein), which was equilibrated with 50 mM potassium
phosphate (pH 8.0) supplemented with 100 mM NaCl,
10% (v/v) glycerol, 0.2 mg/ml E. coli lipids, 0.05% de-
tergent (buffer A), and 10 mM imidazole, and gently
shaken for 60 min at 4°C. The resin was transferred to a
Bio-spin column (Bio-Rad) and subsequently washed
with 20 column volumes of buffer A and 10 mM imida-
zole and 10 column volumes of buffer A and 20 mM im-
idazole. The protein was eluted with buffer A (pH 7.0)
containing 250 mM imidazole, and fractions of 500 µl
were collected. 
A dried film of 1.5 mg E. coli lipids and egg yolk phos-
phatidylcholine in a 3 :1 ratio (w/w) was obtained by
evaporation of chloroform under a flow of nitrogen fol-
lowed by overnight drying under vacuum. Liposomes
were prepared by sonication of the lipid film for 5–8 min
on a 250-W Vibra Cell Sonifier in 2,6 ml of 10 mM 
Tris pH 7.4, 0.5 mM EDTA, 1 mM DTT, 75 mM NaCl.
DDM was added to the sonicated lipid suspension to 
obtain a 1: 2 (w/w) lipid/detergent ratio. The purified
LmrP protein was mixed with the detergent-saturated li-
posomes at a protein to lipid ratio of 1:10 (w/w) and in-
cubated for 30 min at room temperature under gentle ag-
itation. The detergent was then removed by absorption on
SM2 Bio-Beads (three incubations of 2 h under continu-
ous stirring in the presence 80 mg Bio-Beads). To demon-
strate the association of proteins with lipids, the super-
natant collected from the Bio-Beads mixed with an equal
volume of 80% sucrose was overlaid with a 30 to 5% 
sucrose linear gradient and centrifuged overnight at
120,000 g and 4°C in a Beckman L7 ultracentrifuge with
a SW60 rotor. The gradient was fractionated and phos-
pholipid and protein distributions along the gradient were
determined by enzymatic colorimetric assays of the phos-
phatidylcholine and tryptophan fluorescence, respec-
tively. To eliminate the sucrose, the fractions containing
the proteoliposomes were washed twice by centrifugation
in 3 mM Hepes, pH 7.4 for 2 h at 150,000 g and then re-
suspended in ~20 µl of the same buffer.
Imposition of a DpH across LmrP-containing 
liposomes
To impose an artificial proton gradient (DpH), proteoli-
posomes were collected by centrifugation (18,000 g for
30 min at 4°C), resuspended in 20 mM potassium phos-
phate (pH 7.0) supplemented with 100 mM potassium ac-
etate and 2 mM MgSO4 (buffer I, final pH 7.8), followed
by freezelthawing steps in liquid nitrogen. The frozen
proteoliposomes were thawed at room temperature, col-
lected by centrifugation (18,000 g for 30 min at 4°C), and
resuspended to a final concentration of 0.5 mg protein/ml
in buffer I. A 10 µl sample was diluted 100-fold into 20
mM potassium phosphate (pH 7.0) containing 50 mM
K2SO4 and 2 mM MgSO4 (buffer II, final pH 6.9) plus 0.5
µM valinomycin to collapse the electrical potential. 
The DpH across the proteoliposomal membranes was
monitored by measuring the pH-sensitive fluorescence of
pyranine [25]. Pyranine was added in buffer I at a final
concentration of 0.5 mM and encapsulated into lipo-
somes during the freeze-thawing steps described above to
generate the DpH. External pyranine was removed by ex-
tensive washing of the proteoliposomes. The internal pH
was followed by measuring the pyranine fluorescence
(excitation at 461 ± 4 nm, emission 511 ± 4 nm) after di-
lution of 10 µl proteoliposomes into buffer II. Fluores-
cence after complete dissipation of DpH was determined
by addition of 0.5% Triton X-100 into the liposome sus-
pension. A correlation between pyranine fluorescence
and pH was made by measuring the fluorescence of pyra-
nine in buffers at pH values ranging between 6.9 and 7.8.
Hoechst 33342 transport in proteoliposomes
Hoechst 33342 transport in proteoliposomes containing
about 6 µg WT and mutated LmrP was driven by an arti-
ficially imposed DpH (inside alkaline) as explained pre-
viously. Hoechst 33342 in water was added at a final con-
centration of 1 µM to the liposome suspension. In car-
bodiimide labeling experiments, 100 µM of DCCD or
EDAC was added to the proteoliposome suspension. The
fluorescence was monitored on a SLM Aminco 8000 flu-
orimeter using excitation and emission wavelengths of
355 and 457 nm, respectively.
Structural analysis of reconstituted LmrP 
by attenuated total reflection Fourier transform 
infrared spectroscopy (ATR-FTIR)
ATR-FTIR spectra were recorded, at room temperature,
on a Bruker IFS55 FTIR spectrophotometer equipped
with a liquid nitrogen-cooled mercury-cadmium-tel-
luride (MCT) detector at a nominal resolution of 2 cm–1,
and encoded every 1 cm–1. The spectrophotometer was
continuously purged with air dried on an FTIR purge gas
generator 75–62 Balston at a flow rate of 5.8 l/min. The
internal reflection element (ATR) was a germanium plate
(50¥20¥2 mm) with an aperture angle of 45°, yielding 
25 internal reflections [26]. 
The sample contained 20 µg reconstituted WT or mutated
LmrP. Thin films of oriented multilayers were then 
obtained by slowly evaporating the sample on one side 
of the ATR plate, under a stream of nitrogen [26, 27]. 
The ATR plate was then sealed in a universal sample
holder. 
The sample on the ATR plate was rehydrated by flushing
D2O-satured N2 for 2 h, at room temperature. A total of
512 scans were averaged for each measurement. Deter-
mination of the secondary structure was based on the vi-
brational bands of the protein and particularly the amide
I band (1600–1700 cm–1), which is sensitive to the sec-
ondary structure [28]. This amide I band, located in a re-
gion of the spectrum which is often free of other bands, is
composed of 80% pure C=O vibration. The analysis was
performed on the amide I region of deuterated samples
because the H/D exchange allows differentiation of the a-
helical secondary structure from the random secondary
structure whose absorption band shifts from about 1655
cm–1 to about 1642 cm–1 [29]. Fourier self-deconvolution
was applied to increase the resolution of the spectra in the
amide I region. The self-deconvolution was carried out
using a Lorentzian line shape for the deconvolution and a
Gaussian line shape for the apodization [28]. To quantify
the area of the different components of amide I revealed
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by self-deconvolution, a least-squares iterative curve fit-
ting was performed to fit Lorentzian line shapes to the
spectrum between 1700 and 1600 cm–1 [30]. To avoid the
introduction of artifacts due to the self-deconvolution
procedure, the fitting was performed on the non-decon-
voluted spectrum. The proportion of a particular structure
is the sum of the area of all the fitted Lorentzian bands
with their maximum in the frequency region where that
structure occurs divided by the total area of the amide I.
The frequency limits for each structure were first as-
signed according to theoretical [31] or experimental
[32] data: 1662–1645 cm–1, a-helix; 1689–1682 and
1637–1613 cm–1, b sheet; 1644.5–1637 cm–1, random;
1682–1662.5 cm–1, b turns. These limits have been
slightly adjusted to obtain a good agreement between the
proportion of each structure determined by ATR-FTIR
and X-ray crystallography. 
Tryptophan fluorescence quenching by acrylamide
Acrylamide quenching experiments were carried out on
an SLM Aminco 8000 fluorimeter at an excitation wave-
length of 290 nm to reduce the absorbance of acrylamide.
Acrylamide was added from a 3 M solution to the prote-
oliposome suspension containing 6 µg of reconstituted
wild-type or mutated LmrP in the presence or absence of
the various ligands (tetracycline, Hoechst 33342, ethid-
ium bromide, vinblastine and verapamil) and/or the car-
bodiimides (EDAC and DCCD) at a final concentration
of 10 µM and 100 µM, respectively. Fluorescence intensi-
ties were measured at 333 nm after each 5-µl addition of
quencher. Acrylamide quenching data were analyzed ac-
cording to the Stern-Volmer equation for collisional
quenching [33]:
F0/F = 1 + K[Q]
where F0 and F are the fluorescence intensities in the ab-
sence and presence of quencher, [Q] is the molar concen-
tration of quencher, and K is the Stern-Volmer quenching
constant. Data were subjected to a linear fit up to 100 mM
acrylamide. Above this concentration, the static quench-
ing by acrylamide causes a deviation from linearity in
Stern-Volmer plots.
Photoaffinity labeling by [3H]tetracycline
Proteoliposomes containing ~10 µg WT or mutated LmrP
(in buffer I) were collected by centrifugation and resus-
pended in 90 µl buffer II to impose an artificial DpH. For
experiments carried out without DpH, the proteoliposome
were prepared in buffer at a pH ranging from 6 to 8.5 by
freeze/thaw steps and resuspended in the same buffer.
[3H]tetracycline at a final concentration of 10 µM was
added to the proteoliposome suspension, in the presence
or absence of the carbodiimides (EDAC and DCCD) at a
final concentration of 100 µM. After irradiation with 
365 nm UV light for 30 min, 900 µl buffer containing 
1 mM of unlabeled tetracycline was added to stop the la-
beling reaction. Proteoliposomes were collected and
washed in the appropriate buffer by ultracentrifugation at
18,000 g for 30 min at 4°C. Proteoliposomes were resus-
pended in the appropriate buffer and analyzed by SDS-
polyacrylamide gel electrophoresis. After Coomassie
blue staining, the LmrP-containing band was cut and di-
gested in 900 µl 30% H2O2 at 50°C in capped vials
overnight. Ten milliliters of scintillation fluid was added
and the total radioactivity was measured by a Packard
scintillation counter; 100% radioactivity was assigned to
the maximal detected radioactivity whereas 0% was as-
signed to the radioactivity detected in a portion of poly-
acrylamide gel on the lane of protein migration.
Results
Role of membrane-embedded and extramembrane
carboxylic residues in pmf-driven transport activity
of reconstituted LmrP
WT and mutated LmrP were reconstituted by mixing 
purified proteins with DDM-destabilized E. coli/phos-
phatidylcholine vesicles and detergent removal by ad-
sorption on polystyrene beads, essentially as described
previously [19]. Proteoliposomes were layered at the bot-
tom of a linear sucrose gradient and after centrifugation,
the gradient was fractionated from the bottom of the tube.
Comigration of the proteins and the lipids as a single peak
demonstrated that proteoliposomes were formed (data
not shown). The proteoliposome population was homoge-
neous and no aggregates were detectable at the bottom of
the gradient. 
To detect pmf-dependent transport activity of LmrP, a
DpH of 0.9 pH units (interior alkaline) was imposed
across the proteoliposomes as described in Materials and
methods. The pH-sensitive probe pyranine was used to
follow the time-dependent dissipation of this gradient
[25]. The DpH dissipates slowly and reaches half its ini-
tial value after 30 min (fig. 1). All subsequent experi-
ments carried out after imposition of a DpH were moni-
tored within a period of 30 min.
The positively charged Hoechst 33342 is a substrate for
LmrP [11] that is particularly useful in transport mea-
surements because it is highly fluorescent when interca-
lated into the lipid membranes, but virtually non-fluores-
cent in aqueous solution. LmrP-mediated transport was
assayed by measuring the variation in Hoechst 33342 flu-
orescence as a function of time. Hoechst 33342 transport
does not occur in proteoliposomes in the absence of a
DpH. However, when a DpH is imposed, Hoechst 33342
is actively extruded out of the membrane (fig. 2A). No
transport activity was detected in liposomes that did 
not contain LmrP, whether a DpH was imposed or not
(fig. 2A). 
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Figure 1. Measurement of the imposed DpH across LmrP-containing liposomes loaded with pyranine. Pyranine was entrapped in lipo-
somes and a DpH (interior alkaline, DpH = 0.9) imposed as described in Materials and methods Gradient dissipation as a function of time
was evaluated from the pH-dependent pyranine fluorescence shown in the inset (lexc = 461 nm, lem = 511 nm). After 30 min, Triton (0.5%)
was added to solubilize liposomes, and pyranine fluorescence was measured after complete dissipation of the DpH. 
Figure 2. Hoechst 33342 transport in LmrP reconstituted into liposomes. Liposomes with or without inserted WT and mutated LmrP were
diluted 100-fold in the buffer used for reconstitution. DpH across liposomes was imposed as described in Materials and methods. After 30s
of data acquisition (lexc = 355 nm and lem = 457 nm), 5 µl Hoechst 33342 200 µM was added. Fluorescence intensity after addition of
Hoechst 33342 was normalized to 100%. Fluorescence was monitored for ~250 s. Carbodiimide EDAC (C) or DCCD (B) were added to
the proteoliposome suspension at a 100 µM final concentration. When Hoechst 33342 transport was measured on (A) liposomes without
inserted LmrP, with WT- or (C) mutant D68C-, D128C- or (B) D142A-inserted LmrP, traces are annotated ‘Liposomes’, ‘LmrP WT’, 
‘LmrP D68C’, ‘LmrP D128C’ or ‘LmrP D142A’ respectively. ‘DpH’ is annotated when a DpH was imposed across the liposomes. Addition
of EDAC or DCCD is annotated as ‘+EDAC’ or ‘+DCCD’, respectively. 
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The role of carboxylic residues in LmrP-mediated trans-
port was characterized by carbodiimide chemical modi-
fication and mutation of membrane-embedded (D142A)
and extramembrane carboxylic residues (D68C,
D128C). Addition of DCCD, which reacts with car-
boxylic groups located in a hydrophobic environment
[34, 35], inhibited LmrP-mediated transport of Hoechst
33342 (fig. 2B). This observation demonstrates the cru-
cial role of some carboxylic residues located in a hy-
drophobic, probably membrane-embedded environment.
No transport activity was indeed detected with mutant
D142A, suggesting that at least this membrane car-
boxylic residue is necessary for the proper function of
LmrP. After addition of EDAC, which reacts with car-
boxylic groups in hydrophilic environments [34, 35], the
transport process was significantly decreased but still
detectable (fig. 2C). This suggests that some carboxylic
residues located in a hydrophilic environment, probably
Figure 2 (continued)
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in extramembrane loops, are not essential but affect the
efficiency of the LmrP transport process. With mutants
D128C and D68C, inhibition of Hoechst transport activ-
ity was indeed identical to that observed for the WT pro-
tein in the presence of EDAC (fig. 2C).
Mutations introduced in a protein may affect its folding
and can lead to a partial or complete loss of activity even
if the mutated residue has no functional role in the trans-
port process. To verify whether mutations D142A, D68C
and D128C affect LmrP in such a way, the global sec-
ondary-structure content of WT and mutated proteins was
compared. We used ATR-FTIR spectroscopy to obtain in-
formation about the secondary structure of LmrP by
analysis of the amide I band [due to the u(C=O) vibration
of the peptide bonds] of a deuterated sample as previ-
ously described [29]. No change in the amide I shape, and
hence in the secondary structure of the transporter, was
observed after introducing the mutations D142A, D68C
or D128C, indicating that the global structure of LmrP re-
mained unchanged. The effect of these mutations on the
transport activity of LmrP therefore suggests a functional
role for these residues. Moreover, the structural analysis
agreed remarkably well with the predicted model [11] as
it yielded an a-helical estimate of ~60%, corresponding
to 12 transmembrane a helices. The remaining amino
acid residues appear mostly in random structures (30%),
with a minor amount in b sheets (10%), consistent with
the expected structure of the extramembrane connecting
loops. 
Tryptophan accessibility is modified by imposition 
of a pmf and by ligand binding
LmrP contains seven tryptophan residues, four of which
are predicted to be in extramembrane domains [11]. Trp
exposure to the external solvent was determined by mon-
itoring fluorescence intensity in the presence of increas-
ing concentrations (0–100 mM) of the aqueous quencher
acrylamide [33]. Substrates (tetracycline, ethidium bro-
mide, Hoechst 33342) and inhibitors (verapamil and vin-
blastine) [12] were added to proteoliposomes containing
reconstituted LmrP at a final concentration of 10 µM in
the presence or absence of an artificial DpH. Data were
analyzed according to the Stern-Volmer equation, as de-
scribed in Materials and methods.
A first conformation (fig. 3.A; Ksv = 3.07 ± 0.03) was ob-
served when both sides of the liposomes were set at a sim-
ilar pH (6.9 or 7.8). When a DpH (DpH = 0.9, interior al-
kaline) was imposed, the accessibility of the Trp residues
toward the quencher was increased (Ksv = 3.73 ± 0.14).
This observation demonstrates that the pmf modifies the
accessibility of the tryptophan residues located in the cy-
tosolic loops. This change mediated by the pmf still oc-
curred in the presence of DCCD, which reacts with car-
boxylic groups located in hydrophobic environments
(fig. 3A). However, this effect was completely abolished
when EDAC, a carboxylic group reagent that acts in hy-
drophilic environments, was used. These observations
demonstrate that some carboxyl residues located in a hy-
drophilic environment, probably in extramembrane
loops, are required in the pmf-mediated reorganization.
Indeed, in mutants D68C and D128C, the change medi-
ated by the pmf was not detectable (fig. 3B).
When no DpH was imposed (pH 6.9 or 7.8 at both sides
of the membrane), LmrP accessibility was not modified
by the presence of ligands (fig. 3C). This corroborates
observations made on three-dimensional crystals of AcrB
[5]. However, in the presence of a DpH, ligand binding re-
sulted in an increase in Trp residue accessibility toward
the quencher (Ksv = 4.55 ± 0.16; fig. 3C). In D142A LmrP
(fig. 3E), the accessibility of Trp toward the external
medium was still modified by ligand binding but to a
lesser extent than in the WT LmrP (Ksv = 4.09 ± 0.08; fig.
3E). In contrast, after reaction of DCCD with LmrP, the
ligand binding-mediated reorganization was completely
inhibited. Indeed, the accessibility change was similar to
that mediated by the DpH only (fig. 3C). Taken together,
these observations suggest that DCCD reacts with other
residues than Asp142 and that ligand binding-mediated 
restructuring most likely requires several membrane-
embedded carboxylic residues. Another possibility is
that modification of Asp142 by DCCD modifies the nor-
mal folding of LmrP. This hypothesis seems, however,
unlikely. Indeed, structural analysis by ATR-FTIR of WT
LmrP shows no significant modification of the sec-
ondary structure after reaction with DCCD (data not
shown). When the accessibility change mediated by the
pmf was prevented either by adding EDAC or by muta-
tion of residues Asp68 or Asp128, the ligand-mediated re-
structuring was also abolished (fig. 3C, D). This demon-
strates that the pmf-mediated reorganization is necessary
for the subsequent ligand binding-driven conformational
changes. 
Ligand binding to reconstituted LmrP determined
by [3H]tetracycline photolabeling
To identify some of the determinants responsible for drug
affinity modifications during the LmrP-mediated trans-
port process, the binding properties of LmrP to tetracy-
cline, a substrate of LmrP [12], were characterized by
photolabeling. Tetracycline is photoactive and has been
used previously for determining the tetracycline binding
to the metal-tetracycline/H+ antiporter TetA [36]. Briefly,
reconstituted LmrP was incubated with [3H]tetracycline
and then irradiated with UV light for 30 min. Liposomes
were analyzed by SDS-PAGE and Coomassie blue stain-
ing. The band corresponding to LmrP was cut out of the
gel and its radioactivity was measured. Irradiation of pro-
teoliposomes containing LmrP with UV light for 30 min
in the presence of [3H]tetracycline resulted in LmrP-as-
sociated radioactivity (fig. 4A). In contrast, when lipo-
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Figure 3. Stern-Volmer plots of tryptophan quenching by acrylamide in reconstituted LmrP. F is the measured Trp fluorescence intensity
and F0 is the fluorescence in the absence of acrylamide. Experiments were completed within 5 min, and the dissipation of an imposed DpH
is very small. The curves are the means of at least three experiments. (A)  WT LmrP without imposition of a DpH (); WT LmrP after im-
position of a DpH (); WT LmrP after imposition of a DpH in the presence of 100 µM EDAC (); WT LmrP after imposition of a DpH in
the presence of 100 µM DCCD (). (B) WT LmrP without imposition of a DpH (); WT LmrP after imposition of a DpH (); D68C LmrP
without imposition of a DpH (); D68C LmrP after imposition of a DpH (); D128C LmrP without imposition of a DpH (); D128C LmrP
after imposition of a DpH (). (C) WT LmrP without imposition of a DpH (); WT LmrP after imposition of a DpH (); WT LmrP with-
out imposition of a DpH in the presence of 10 µM substrates (); WT LmrP after imposition of a DpH in the presence of 10 µM substrates
(); WT LmrP after imposition of a DpH in the presence of 10 µM substrates and 100 µM DCCD (); WT LmrP after imposition of a DpH
in the presence of 10 µM substrates and 100 µM EDAC (). (D) WT LmrP without imposition of a DpH (); WT LmrP after imposition
of a DpH (); WT LmrP after imposition of a DpH in the presence of 10 µM substrates (); D68C LmrP after imposition of a DpH in the
presence of 10 µM substrates (); D128C LmrP after imposition of a DpH in the presence of 10 µM substrates (). 
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Figure 3 (continued) (E) WT LmrP without imposition of a DpH
(); WT LmrP after imposition of a DpH (); WT LmrP after im-
position of a DpH in the presence of 10 µM substrates (); D142A
LmrP after imposition of a DpH (); D142A LmrP after imposition
of a DpH in the presence of 10 µM substrates ().
somes that did not contain LmrP were incubated in the
presence of [3H]tetracycline and irradiated, no significant
radioactivity was detected. These observations demon-
strate that tetracycline binds specifically to reconstituted
LmrP. 
To determine the pH dependence of tetracycline binding
to LmrP, [3H] tetracycline labeling was carried out in a pH
range from 6 to 8.5. Tetracycline labeling increased from
pH ~6 to pH ~8 and was maximal above pH 8.5 (fig. 4A).
To test whether membrane-embedded carboxylic resi-
dues are involved in this pH-dependent ligand binding,
the effect of DCCD and a D142C mutation of LmrP were
investigated (fig. 4A). Hydrophobic DCCD completely
inhibited tetracycline labeling of LmrP. A D142A muta-
tion of LmrP caused a decreased affinity for tetracycline,
but less pronounced than in the presence of DCCD. All
these data are consistent with the idea that the drug- bind-
ing site is located in the membrane-embedded region of
the protein and contains several carboxylic amino acid
residues. Moreover, protonation/deprotonation of these
membrane-embedded carboxyl residues including resi-
due Asp142 seems necessary to modify drug affinity dur-
ing the transport process. Indeed, when residue Asp142
was replaced with an alanine, tetracycline binding was
still pH dependent but showed an inflection around 6.5
instead of at pH 7.5 in the WT LmrP. This shift suggests
that several residues with different pKa cooperate in
LmrP substrate affinity. 
When a DpH was imposed across the membrane (DpH =
0.9, interior alkaline), the tetracycline labeling was in-
creased 2.5-fold compared to the labeling observed
around pH 8.5 (fig. 4B). This demonstrates for the first
time that the pmf across the lipidic membrane stimulates
drug binding. The fact that the hydrophilic EDAC had no
effect on the pH dependency of tetracycline binding (fig.
4C) but inhibited the stimulatory effect of the pmf (fig.
4B) suggests a role for some carboxylic residues located
in a hydrophilic environment in the pmf-driven stimula-
tion. This was confirmed with mutant D128C (fig. 4B,
C). Whereas its drug affinity in the absence of a DpH was
similar to the WT protein, no stimulation occured after
imposition of the DpH. 
The affinity of mutant D68C for tetracycline was reduced
even in the absence of a DpH (fig. 4C). This means, in ad-
dition to earlier proposals [19], that some residues lo-
cated in extramembrane domains may modulate LmrP
substrate affinity. 
Discussion
In this study, we used the purified and liposome-reconsti-
tuted secondary MDR transporter LmrP to investigate the
impact of the pmf on the structure and ligand binding of
LmrP. The results demonstrate that imposition of a DpH
across the lipidic membrane modifies globally the struc-
ture of LmrP. Indeed, the DpH was demonstrated to medi-
ate a conformational change of LmrP that stimulates its
drug affinity. These results provide, to the best of our
knowledge, the first experimental evidence that the pmf
modifies the affinity of a secondary transporter for a sub-
strate. Mutation of carboxylic residues Asp68 and Asp128,
located in the extramembrane domain of the protein abol-
ishes this effect. As suggested by Yu et al. [5], this pmf-
mediated restructuring may be essential in other sec-
ondary MDR transporters such as AcrB. 
In agreement with the data obtained from the three-di-
mensional crystals of ligand-bound AcrB [5], no ligand-
induced (tetracycline, ethidium bromide, Hoechst
33342, verapamil, vinblastine) accessibility changes of
LmrP were observed in the absence of a pmf. Notably,
drug binding in the presence of the DpH mediates a
change that increases LmrP accessibility toward the hy-
drophilic quencher. Several membrane-embedded resi-
dues including Asp142 are involved in this restructuring
which may be related to the translocation of the drug
binding site from a membrane-facing orientation toward
an external medium-facing orientation, in favor of drug
release. The fluorescence quenching was similar for all
ligands used, indicating that the conformational changes
required for transport are similar for drugs with different
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Figure 4. Effect of pH on photolabeling by [3H]tetracycline of reconstituted LmrP. Reconstituted LmrP was incubated with [3H]tetracy-
cline and irradiated with UV light. The sample was run on SDS-PAGE, cut out of the gel, and radioactivity associated with the protein was
determined by a Packard scintillation counter. [3H]tetracycline labeling was carried out in buffers that covered a pH range from 6 to 8.5.
100 % was assigned to the maximal radioactivity detected at pH 8.5 whereas 0% was assigned to the radioactivity detected in a portion of
SDS-PAGE on the lane of the protein. (A) Tetracycline binding on liposomes only (); WT LmrP-containing liposomes (); WT LmrP-
containing liposomes in the presence of 100 µM DCCD () and D142A LmrP-containing liposomes (). (B) Tetracycline binding on WT
or D128C at pH 8.5 (hatched bars) or after imposition of a DpH (gray bars) and for WT after imposition of a DpH in the presence of 
100 µM EDAC (white bars). (C) Tetracycline binding on WT LmrP-containing liposomes (); WT LmrP-containing liposomes in the pres-
ence of 100 µM EDAC (); D68C LmrP-containing liposomes () and D128C LmrP-containing liposomes (). 
interaction sites with LmrP. Reorganization of the cy-
tosolic domains due to the pmf is a prerequisite for the
subsequent ligand binding-mediated restructuring. Pre-
viously, maleimide-labeling studies of cysteine mutants
of LmrP demonstrated that in the absence of a pmf, the
membrane-embedded Asp142 and Glu327 move from a sol-
vent-inaccessible to a solvent-exposed environment
upon interaction with substrates [19]. However, the frac-
tion of LmrP labeled by maleimide was small under
these conditions, and may indicate that observed
changes are limited in the absence of a pmf. These ob-
servations, together with the data presented here, sug-
gests that the pmf and in particular the DpH are not nec-
essary for substrate binding but are crucial at least for a
restructuring of LmrP that stimulates ligand binding dur-
ing the transport process. 
We demonstrated that tetracycline binding is pH depen-
dent. Indeed, it increases significantly between pH 6.5
and 8.5 suggesting that deprotonation of the drug-bind-
ing site is required for ligand binding, and protonation
for drug release. The inhibitory action of carbodiimides
suggests that carboxylic residues located in a hydro-
phobic environment, probably membrane-embedded, are
responsible for this pH-dependent drug affinity of LmrP.
Substrate binding depending on the protonation state 
of membraneous carboxylic residues has also been
demonstrated for the E. coli drug transporter EmrE [18].
After replacement of residue Asp142 by an alanine, tetra-
cycline binding decreases, showing that the carboxylic
residue Asp142 is involved in this LmrP pH-dependent
drug binding. The shift of the apparent pKa of tetracy-
cline binding to the D142A mutant from ~7.5 to ~6.5
raises the idea that several membrane-embedded car-
boxylic residues with different pKas cooperate to modu-
late LmrP affinity for drugs. A carboxylic residue lo-
cated in an extramembrane loop was also demonstrated
to modulate drug binding to LmrP. Namely, after muta-
tion of residue Asp68 to Cys, drug binding is drastically
reduced. However, it is not clear if this phenomenon re-
sults from a direct involvement of this aspartate in sub-
strate binding. This suggests that LmrP may require a
more complex mode than Emr E for coupling H+ and
drug translocation.
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